Bottneuro: Funding, Investors & Team (Sep 2026)
Bottneuro is developing a non-invasive, home-based tCS/EEG therapy system for AD patients, using personalized transcranial electrical stimulation. Our innovative method consists of periodic brain stimulation sessions, applied through fully personalized, 3D-printed, wearable headsets. It integrates software and hardware components, including a tablet, a neckpiece containing the electronics and in-house developed brush electrodes, no shaving is needed. Based on MRI and PET scans of the patient’s head, electrode placement is calculated to stimulate only disease affected regions. The 3D-printed cap enables a repeated and precise electrode position for each stimulation session.
Bottneuro has raised $4.3M across 1 funding round on record, the most recent an undisclosed round of $4.3M announced in Dec 2022.
That round is in line with the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Bottneuro Company Profile and Key Stats
Latest funding round on record: Dec 2022.
Bottneuro Funding Rounds
Bottneuro Founders and Leadership Team
No contact details are on record for this team yet.
Bottneuro Funding Compared to Other Health Care Startups
Bottneuro's latest round of $4.3M is in line with the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Bottneuro in Health Care and Basel
Companies Similar to Bottneuro
MoleSense is to provide a wearable skin sensor to help monitor high-risk pregnancies.
CeQur Simplicity helps people with diabetes by developing drug-delivery devices. They develop bolus insulin…
Calmea develops advanced contactless sensing systems that invisibly track sleep and automatically modify…
NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for…
UNBOOUND is a medtech company and university spin-off (The Rockefeller University and University of Geneva)…
Christina Vallgren and Marcus Palm, two physicists from CERN, co-founded Terapet along with Professor Raymond…
Axmed is a company that specializes in serving low and middle-income countries (LMICs), with the goal of…
Babylat is an enricher device is the first automated, small-scale tabletop device for the protein enrichment…
Altiscreen is creating and producing cutting-edge, portable drug-of-abuse detection systems. With the use of…
Vivent provides growers, breeders and agrochem companies with actionable information direct from plants…
Multiwave develops breakthrough Magnetic Resonance Imaging and Positron Emission Tomography devices. Founded…
Bottneuro Funding FAQs
What does Bottneuro do?
Bottneuro is developing a non-invasive, home-based tCS/EEG therapy system for AD patients, using personalized transcranial electrical stimulation. Our innovative method consists of periodic brain stimulation sessions, applied through fully personalized, 3D-printed, wearable headsets. It integrates software and hardware components, including a tablet, a neckpiece containing the electronics and in-house developed brush electrodes, no shaving is needed. Based on MRI and PET scans of the patient’s head, electrode placement is calculated to stimulate only disease affected regions. The 3D-printed cap enables a repeated and precise electrode position for each stimulation session.
How much funding has Bottneuro raised?
Bottneuro has raised $4.3M across 1 round on record. The most recent is an undisclosed round of $4.3M announced in Dec 2022.
When did Bottneuro last raise funding?
Bottneuro's most recent funding round on record is an undisclosed round of $4.3M, announced in Dec 2022.
Who founded Bottneuro?
FundedIQ lists Alois Hopf (Founder) at Bottneuro.
Where is Bottneuro headquartered?
Bottneuro is based in Basel, Basel-Stadt, Switzerland.
How many employees does Bottneuro have?
Bottneuro is in the 11-50 employee band.
How does Bottneuro's funding compare to other Health Care startups?
Bottneuro's latest round of $4.3M is in line with the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Bottneuro Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Bottneuro is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.